General Information of Disease (ID: DISJFK9W)

Disease Name Early-onset posterior polar cataract
Disease Hierarchy
DIS6W7YF: Cataract 16 multiple types
DISJFK9W: Early-onset posterior polar cataract
Disease Identifiers
MONDO ID
MONDO_0020378
UMLS CUI
C0858617
MedGen ID
163646
HPO ID
HP:0007787
Orphanet ID
98993
SNOMED CT ID
315353005

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 11 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
CRYAB TT7RUHB Limited GermlineCausalMutation [1]
EPHA2 TTRJB2G Limited Genetic Variation [2]
CHMP4B TT09EZF Supportive Autosomal dominant [3]
EPHA2 TTRJB2G Supportive Autosomal dominant [4]
GJA3 TTFZRG0 Supportive Autosomal dominant [5]
CHMP4B TT09EZF Strong GermlineCausalMutation [3]
GJA3 TTFZRG0 Strong GermlineCausalMutation [5]
LSS TT7O8ZA Strong Biomarker [6]
NUCB1 TT6A5ZL Strong Biomarker [7]
PNPLA3 TTEUAEH Strong Genetic Variation [8]
TM6SF2 TTE1OHM Strong Genetic Variation [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 DTT(s)
This Disease Is Related to 15 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CHMP4B OT854ZK7 Supportive Autosomal dominant [3]
CRYAB OTY4JGYU Supportive Autosomal dominant [9]
CRYBA1 OT8617WJ Supportive Autosomal dominant [10]
EPHA2 OTI6QNX2 Supportive Autosomal dominant [4]
GJA3 OTXV6ETF Supportive Autosomal dominant [5]
MIP OTEBLU3E Supportive Autosomal dominant [11]
PANK4 OTMLNEPU Supportive Autosomal dominant [12]
PITX3 OTE2KT8P Supportive Autosomal dominant [13]
ACAD8 OT3JI5GB moderate Biomarker [14]
CRYBB2 OTL0Z8E6 Strong Genetic Variation [15]
DCT OTYVNTBG Strong Biomarker [16]
HSF4 OT1UX9SK Strong Biomarker [17]
LAMA3 OTFME7HT Strong Biomarker [18]
RLN2 OTY3OG71 Strong Biomarker [19]
STATH OTQHBHM9 Strong Genetic Variation [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 DOT(s)

References

1 A novel P20R mutation in the alpha-B crystallin gene causes autosomal dominant congenital posterior polar cataracts in a Chinese family.BMC Ophthalmol. 2014 Sep 8;14:108. doi: 10.1186/1471-2415-14-108.
2 A Novel Human Congenital Cataract Mutation in EPHA2 Kinase Domain (p.G668D) Alters Receptor Stability and Function.Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4717-4726. doi: 10.1167/iovs.19-27370.
3 CHMP4B, a novel gene for autosomal dominant cataracts linked to chromosome 20q. Am J Hum Genet. 2007 Sep;81(3):596-606. doi: 10.1086/519980. Epub 2007 Jul 27.
4 Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract. Hum Mutat. 2009 May;30(5):E603-11. doi: 10.1002/humu.20995.
5 Molecular analysis of cataract families in India: new mutations in the CRYBB2 and GJA3 genes and rare polymorphisms. Mol Vis. 2010 Sep 10;16:1837-47.
6 Tumor suppressor gene, cell surface adhesion molecule, and multidrug resistance in Mllerian serous carcinomas: clinical divergence without immunophenotypic differences.Gynecol Oncol. 2000 Dec;79(3):430-7. doi: 10.1006/gyno.2000.6000.
7 Amyloid 1-43 Accumulates in the Lens Epithelium of Cortical Opacification in Japanese Patients.Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3294-3302. doi: 10.1167/iovs.17-22065.
8 PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.PLoS One. 2018 Aug 30;13(8):e0202942. doi: 10.1371/journal.pone.0202942. eCollection 2018.
9 Identification of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family. Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3461-6. doi: 10.1167/iovs.05-1438.
10 A splice site mutation in CRYBA1/A3 causing autosomal dominant posterior polar cataract in a Chinese pedigree. Mol Vis. 2010 Feb 5;16:154-60.
11 A novel nonsense mutation in the MIP gene linked to congenital posterior polar cataracts in a Chinese family. PLoS One. 2015 Mar 24;10(3):e0119296. doi: 10.1371/journal.pone.0119296. eCollection 2015.
12 A novel mutation of PANK4 causes autosomal dominant congenital posterior cataract. Hum Mutat. 2019 Apr;40(4):380-391. doi: 10.1002/humu.23696. Epub 2019 Jan 23.
13 The PITX3 gene in posterior polar congenital cataract in Australia. Mol Vis. 2006 Apr 18;12:367-71.
14 Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.J Crohns Colitis. 2019 Sep 27;13(10):1239-1247. doi: 10.1093/ecco-jcc/jjz088.
15 Characterization of a novel mutation in the CRYBB2 gene associated with autosomal dominant congenital posterior subcapsular cataract in a Chinese family. Mol Vis. 2011 Jan 13;17:144-52.
16 Development and characterization of naive single-type tumor antigen-specific CD8(+) T lymphocytes from murine pluripotent stem cells.Oncoimmunology. 2017 May 30;6(7):e1334027. doi: 10.1080/2162402X.2017.1334027. eCollection 2017.
17 Copy number variations of DNA repair genes and the age-related cataract: Jiangsu Eye Study.Invest Ophthalmol Vis Sci. 2013 Feb 1;54(2):932-8. doi: 10.1167/iovs.12-10948.
18 The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.Am J Ophthalmol. 2019 May;201:63-71. doi: 10.1016/j.ajo.2019.01.025. Epub 2019 Feb 2.
19 Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.J Control Release. 2018 Nov 28;290:1-10. doi: 10.1016/j.jconrel.2018.09.031. Epub 2018 Oct 2.